282 related articles for article (PubMed ID: 9498741)
1. IFN-gamma is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways.
Konieczny BT; Dai Z; Elwood ET; Saleem S; Linsley PS; Baddoura FK; Larsen CP; Pearson TC; Lakkis FG
J Immunol; 1998 Mar; 160(5):2059-64. PubMed ID: 9498741
[TBL] [Abstract][Full Text] [Related]
2. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways.
Larsen CP; Elwood ET; Alexander DZ; Ritchie SC; Hendrix R; Tucker-Burden C; Cho HR; Aruffo A; Hollenbaugh D; Linsley PS; Winn KJ; Pearson TC
Nature; 1996 May; 381(6581):434-8. PubMed ID: 8632801
[TBL] [Abstract][Full Text] [Related]
3. Genetic characterization of strain differences in the ability to mediate CD40/CD28-independent rejection of skin allografts.
Williams MA; Trambley J; Ha J; Adams AB; Durham MM; Rees P; Cowan SR; Pearson TC; Larsen CP
J Immunol; 2000 Dec; 165(12):6849-57. PubMed ID: 11120808
[TBL] [Abstract][Full Text] [Related]
4. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
[TBL] [Abstract][Full Text] [Related]
5. Blocking the CD28-B7 T cell costimulation pathway induces long term cardiac allograft acceptance in the absence of IL-4.
Lakkis FG; Konieczny BT; Saleem S; Baddoura FK; Linsley PS; Alexander DZ; Lowry RP; Pearson TC; Larsen CP
J Immunol; 1997 Mar; 158(5):2443-8. PubMed ID: 9036995
[TBL] [Abstract][Full Text] [Related]
6. Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4(+) T cells, interferon-gamma, and CTLA4.
Markees TG; Phillips NE; Gordon EJ; Noelle RJ; Shultz LD; Mordes JP; Greiner DL; Rossini AA
J Clin Invest; 1998 Jun; 101(11):2446-55. PubMed ID: 9616216
[TBL] [Abstract][Full Text] [Related]
7. The role of the IL-2 pathway in costimulation blockade-resistant rejection of allografts.
Jones TR; Ha J; Williams MA; Adams AB; Durham MM; Rees PA; Cowan SR; Pearson TC; Larsen CP
J Immunol; 2002 Feb; 168(3):1123-30. PubMed ID: 11801646
[TBL] [Abstract][Full Text] [Related]
8. The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term allograft survival.
Judge TA; Wu Z; Zheng XG; Sharpe AH; Sayegh MH; Turka LA
J Immunol; 1999 Feb; 162(4):1947-51. PubMed ID: 9973463
[TBL] [Abstract][Full Text] [Related]
9. Interference with CD28, CD80, CD86 or CD152 in collagen-induced arthritis. Limited role of IFN-gamma in anti-B7-mediated suppression of disease.
Tellander AC; Pettersson U; Runström A; Andersson M; Michaëlsson E
J Autoimmun; 2001 Aug; 17(1):39-50. PubMed ID: 11488636
[TBL] [Abstract][Full Text] [Related]
10. Cutting edge: blockade of the CD28/B7 costimulatory pathway inhibits intestinal allograft rejection mediated by CD4+ but not CD8+ T cells.
Newell KA; He G; Guo Z; Kim O; Szot GL; Rulifson I; Zhou P; Hart J; Thistlethwaite JR; Bluestone JA
J Immunol; 1999 Sep; 163(5):2358-62. PubMed ID: 10452966
[TBL] [Abstract][Full Text] [Related]
11. Regulation of alloantigen-mediated T-cell proliferation by endogenous interferon-gamma: implications for long-term allograft acceptance.
Hassan AT; Dai Z; Konieczny BT; Ring GH; Baddoura FK; Abou-Dahab LH; El-Sayed AA; Lakkis FG
Transplantation; 1999 Jul; 68(1):124-9. PubMed ID: 10428279
[TBL] [Abstract][Full Text] [Related]
12. Impaired alloantigen-mediated T cell apoptosis and failure to induce long-term allograft survival in IL-2-deficient mice.
Dai Z; Konieczny BT; Baddoura FK; Lakkis FG
J Immunol; 1998 Aug; 161(4):1659-63. PubMed ID: 9712028
[TBL] [Abstract][Full Text] [Related]
13. Blockade of CD40 pathway enhances the induction of immune tolerance by immature dendritic cells genetically modified to express cytotoxic T lymphocyte antigen 4 immunoglobulin.
Sun W; Wang Q; Zhang L; Liu Y; Zhang M; Wang C; Wang J; Cao X
Transplantation; 2003 Nov; 76(9):1351-9. PubMed ID: 14627915
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of allorecognition and skin graft rejection in CD28 and CD40 ligand double-deficient mice.
Habiro K; Kotani M; Omoto K; Kobayashi S; Tanabe K; Shimmura H; Suzuki K; Hayashi T; Toma H; Abe R
Transplantation; 2003 Sep; 76(5):854-8. PubMed ID: 14501867
[TBL] [Abstract][Full Text] [Related]
15. Transplant long-surviving induced by CD40-CD40 ligand costimulation blockade is dependent on IFN-γ through its effect on CD4(+)CD25(+) regulatory T cells.
Jiang XF; Zhu L; Cui ZM; Guo DW; Sun WY; Lin L; Tang YF; Wang XF; Liang J
Transpl Immunol; 2011 Jan; 24(2):113-8. PubMed ID: 20955795
[TBL] [Abstract][Full Text] [Related]
16. Anergic cells induced by the blockade of CD40-CD154 and CD28-B7 costimulatory pathways act as potent immunoregulatory cells in vitro and vivo.
Cai Y; Zhou PJ; Tang XD
Chin Med J (Engl); 2004 Aug; 117(8):1178-83. PubMed ID: 15361291
[TBL] [Abstract][Full Text] [Related]
17. The role of the CD40 pathway in alloantigen-induced hyporesponsiveness in vivo.
Niimi M; Pearson TC; Larsen CP; Alexander DZ; Hollenbaugh D; Aruffo A; Linsley PS; Thomas E; Campbell K; Fanslow WC; Geha RS; Morris PJ; Wood KJ
J Immunol; 1998 Nov; 161(10):5331-7. PubMed ID: 9820506
[TBL] [Abstract][Full Text] [Related]
18. Expression of B7 molecules in recipient, not donor, mice determines the survival of cardiac allografts.
Mandelbrot DA; Furukawa Y; McAdam AJ; Alexander SI; Libby P; Mitchell RN; Sharpe AH
J Immunol; 1999 Oct; 163(7):3753-7. PubMed ID: 10490971
[TBL] [Abstract][Full Text] [Related]
19. Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation.
Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Buhlman J; Xu J; Flavell RA; Korngold R; Noelle R; Vallera DA
J Immunol; 1997 Jan; 158(1):29-39. PubMed ID: 8977172
[TBL] [Abstract][Full Text] [Related]
20. Aggressive skin allograft rejection in CD28-/- mice independent of the CD40/CD40L costimulatory pathway.
Ha J; Bingaman AW; Durham MM; Pearson TC; Larsen CP
Transpl Immunol; 2001 Oct; 9(1):13-7. PubMed ID: 11680567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
